S M Machekera1, E Wilkinson2, S G Hinderaker3, M Mabhala4, C Zishiri1, R T Ncube1, C Timire1,5, K C Takarinda1,5, T Sengai6, C Sandy5. 1. International Union Against Tuberculosis and Lung Diseases, Harare, Zimbabwe. 2. Institute of Medicine, University of Chester, Chester, UK. 3. Centre of International Health, University of Bergen, Bergen, Norway. 4. Department of Public Health and Wellbeing, University of Chester, Chester, UK. 5. Ministry of Health and Child Care, Harare, Zimbabwe. 6. Family AIDS Caring Trust, Mutare, Zimbabwe.
Abstract
SETTING: Ten districts and three cities in Zimbabwe. OBJECTIVE: To compare the yield and relative cost of identifying a case of tuberculosis (TB) using the three WHO-recommended algorithms (WHO2b, symptom inquiry only; WHO2d, chest X-ray [CXR] after a positive symptom inquiry; WHO3b, CXR only) and the Zimbabwe active case finding (ZimACF) algorithm (symptom inquiry plus CXR) to everyone. DESIGN: Cross-sectional study using data from the ZimACF project. RESULTS: A total of 38 574 people were screened from April to December 2017; 488 (1.3%) were diagnosed with TB using the ZimACF algorithm. Fewer TB cases would have been diagnosed with the WHO-recommended algorithms. This ranged from 7% fewer (34 cases) with WHO3b, 18% fewer (88 cases) with WHO2b and 25% fewer (122 cases) with WHO2d. The need for CXR ranged from 36% (WHO2d) to 100% (WHO3b). The need for bacteriological confirmation ranged from 7% (WHO2d) to 40% (ZimACF). The relative cost per case of TB diagnosed ranged from US$180 with WHO3b to US$565 for the ZimACF algorithm. CONCLUSION: The ZimACF algorithm had the highest case yield, but at a much higher cost per case than the WHO algorithms. It is possible to switch to algorithm WHO3b, but the trade-off between cost and yield needs to be reviewed by the Zimbabwean National TB Programme.
SETTING: Ten districts and three cities in Zimbabwe. OBJECTIVE: To compare the yield and relative cost of identifying a case of tuberculosis (TB) using the three WHO-recommended algorithms (WHO2b, symptom inquiry only; WHO2d, chest X-ray [CXR] after a positive symptom inquiry; WHO3b, CXR only) and the Zimbabwe active case finding (ZimACF) algorithm (symptom inquiry plus CXR) to everyone. DESIGN: Cross-sectional study using data from the ZimACF project. RESULTS: A total of 38 574 people were screened from April to December 2017; 488 (1.3%) were diagnosed with TB using the ZimACF algorithm. Fewer TB cases would have been diagnosed with the WHO-recommended algorithms. This ranged from 7% fewer (34 cases) with WHO3b, 18% fewer (88 cases) with WHO2b and 25% fewer (122 cases) with WHO2d. The need for CXR ranged from 36% (WHO2d) to 100% (WHO3b). The need for bacteriological confirmation ranged from 7% (WHO2d) to 40% (ZimACF). The relative cost per case of TB diagnosed ranged from US$180 with WHO3b to US$565 for the ZimACF algorithm. CONCLUSION: The ZimACF algorithm had the highest case yield, but at a much higher cost per case than the WHO algorithms. It is possible to switch to algorithm WHO3b, but the trade-off between cost and yield needs to be reviewed by the Zimbabwean National TB Programme.
Authors: Nguyen Binh Hoa; Dinh Ngoc Sy; Nguyen Viet Nhung; Edine W Tiemersma; Martien W Borgdorff; Frank G J Cobelens Journal: Bull World Health Organ Date: 2010-02-22 Impact factor: 9.408
Authors: Karen R Steingart; Hojoon Sohn; Ian Schiller; Lorie A Kloda; Catharina C Boehme; Madhukar Pai; Nandini Dendukuri Journal: Cochrane Database Syst Rev Date: 2013-01-31
Authors: Vladimir N Kuznetsov; Andrej M Grjibovski; Andrey O Mariandyshev; Eva Johansson; Gunnar A Bjune Journal: Int J Circumpolar Health Date: 2014-02-14 Impact factor: 1.228
Authors: Anna H van't Hoog; Helen K Meme; Kayla F Laserson; Janet A Agaya; Benson G Muchiri; Willie A Githui; Lazarus O Odeny; Barbara J Marston; Martien W Borgdorff Journal: PLoS One Date: 2012-07-06 Impact factor: 3.240
Authors: Helen Ayles; Albertus Schaap; Amos Nota; Charalambos Sismanidis; Ruth Tembwe; Petra De Haas; Monde Muyoyeta; Nulda Beyers Journal: PLoS One Date: 2009-05-19 Impact factor: 3.240
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: PLoS Med Date: 2007-10-16 Impact factor: 11.069
Authors: B Odume; E Chukwu; T Fawole; N Nwokoye; C Ogbudebe; O Chukwuogo; S Useni; C Dim; E Ubochioma; D Nongo; R Eneogu; T Lagundoye Odusote; O Oyelaran; C Anyaike Journal: Public Health Action Date: 2022-06-21
Authors: Joanitah Nalunjogi; Frank Mugabe; Irene Najjingo; Pastan Lusiba; Francis Olweny; Joseph Mubiru; Edward Kayongo; Rogers Sekibira; Achilles Katamba; Bruce Kirenga Journal: Tuberc Res Treat Date: 2021-03-19